Item 4.01 Changes in Registrant's Certifying Accountant.

On April 29, 2024, the Audit Committee of the Board of Directors of Lifecore Biomedical, Inc. (the "Company") approved the engagement of BDO USA, P.C. ("BDO") as the Company's independent registered public accounting firm, effective immediately, to perform audit services for the fiscal year ending May 26, 2024.

During the two most recent fiscal years ended May 28, 2023 and May 29, 2022 and during the subsequent interim period from May 29, 2023 through the date of this filing, neither the Company nor anyone on its behalf consulted BDO regarding either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements, and neither a written report nor oral advice was provided to the Company that was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue, or (ii) any matter that was either the subject of a "disagreement" or a "reportable event," each as defined in Regulation S-K Item 304(a)(1)(iv) and 304(a)(1)(v), respectively.













2


Attachments

  • Original Link
  • Permalink

Disclaimer

Lifecore Biomedical Inc. published this content on 30 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 May 2024 09:09:23 UTC.